期刊
GENES
卷 11, 期 1, 页码 -出版社
MDPI
DOI: 10.3390/genes11010105
关键词
inherited eye disease; ophthalmic genetics; genomics; next generation sequencing; retinopathy; rare variants; novel variants
资金
- Fighting Blindness Ireland (FB Irl) [FB16FAR, FB18CRE]
- Health Research Board of Ireland (HRB) [POR/2010/97]
- Health Research Charities Ireland (HRCI) [MRCG-2013-8, MRCG-2016-14]
- Irish Research Council (IRC) [GOIPG/2017/1631]
- Science Foundation Ireland (SFI) [16/1A/4452]
- Health Research Board (HRB) [MRCG-2016-14, MRCG-2013-8] Funding Source: Health Research Board (HRB)
- Irish Research Council (IRC) [GOIPG/2017/1631] Funding Source: Irish Research Council (IRC)
The Irish national registry for inherited retinal degenerations (Target 5000) is a clinical and scientific program to identify individuals in Ireland with inherited retinal disorders and to attempt to ascertain the genetic cause underlying the disease pathology. Potential participants first undergo a clinical assessment, which includes clinical history and analysis with multimodal retinal imaging, electrophysiology, and visual field testing. If suitable for recruitment, a sample is taken and used for genetic analysis. Genetic analysis is conducted by use of a retinal gene panel target capture sequencing approach. With over 1000 participants from 710 pedigrees now screened, there is a positive candidate variant detection rate of approximately 70% (495/710). Where an autosomal recessive inheritance pattern is observed, an additional 9% (64/710) of probands have tested positive for a single candidate variant. Many novel variants have also been detected as part of this endeavor. The target capture approach is an economic and effective means of screening patients with inherited retinal disorders. Despite the advances in sequencing technology and the ever-decreasing associated processing costs, target capture remains an attractive option as the data produced is easily processed, analyzed, and stored compared to more comprehensive methods. However, with decreasing costs of whole genome and whole exome sequencing, the focus will likely move towards these methods for more comprehensive data generation.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据